Beam Therapeutics Inc

{ "date": [ "202612", "202712", "202812" ], "revenue_estimate": [ 48.85, 64.57, 129.86 ], "ebit_estimate": [ -516.19, -551.87, -505.56 ], "ebitda_estimate": [ -478.52, -514.23, -479.61 ], "net_income_estimate": [ -483.8, -527.18, -539.53 ], "per_share_eps_estimate": [ -4.63, -4.62, -4.41 ], "eps_nri_estimate": [ -4.61, -4.71, -4.47 ], "dividend_estimate": [ null, null, null ], "book_value_per_share_estimate": [ 7.3, 7.25, 6.3 ], "pretax_income_estimate": [ -484.34, -532.57, -547.61 ], "operating_cash_flow_per_share_estimate": [ -3.82, -3.56, -3.44 ], "roa_estimate": [ -32.1, -41.3, null ], "roe_estimate": [ -45.11, -69.2, -138.97 ], "gross_margin_estimate": [ 100, 92.97, 88.79 ], "operating_cash_flow_estimate": [ -392.82, -366.4, -354.05 ], "pettm_estimate": [ 0, 0, 0 ], "long_term_growth_rate_mean": -64.38, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -66.21, "future_eps_nri_estimate_growth": -64.38, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -9.36, "future_ebitda_estimate_growth": -9.65, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -78.82, "future_pretax_income_estimate_growth": -79.78, "future_book_value_per_share_estimate_growth": -17.98, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -144.76, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202603", "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 11.28, 11.58, 11.84, 12.5, 16.57, 16.57, 16.57, 20.33 ], "ebit_estimate": [ -122.19, -127, -132.46, -136.24, -144, -144, -151, -151 ], "ebitda_estimate": [ -109.91, -113.85, -119.79, -124.14, null, null, null, null ], "net_income_estimate": [ -113.02, -117.51, -123.45, -130.08, -141.2, -141.5, -152.8, -153.1 ], "per_share_eps_estimate": [ -1.1, -1.13, -1.18, -1.22, -1.26, -1.29, -1.29, -1.27 ], "eps_nri_estimate": [ -1.09, -1.12, -1.17, -1.23, -1.27, -1.29, -1.29, -1.27 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -113.27, -118.75, -124.37, -128.9, -141.2, -141.5, -152.8, -153.1 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -39.25, -45.19, -52.79, -62.77, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": -64.38, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -66.21, "future_eps_nri_estimate_growth": -64.38, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -9.36, "future_ebitda_estimate_growth": -9.65, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -78.82, "future_pretax_income_estimate_growth": -79.78, "future_book_value_per_share_estimate_growth": -17.98, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -144.76, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }